Dr. Streby is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
700 Childrens Dr
Columbus, OH 43205Phone+1 614-722-3552Fax+1 614-722-3699
Summary
- Dr. Keri Streby is a pediatric hematologist/oncologist in Columbus, OH and is affiliated with Nationwide Children's Hospital. She received her medical degree from Northeast Ohio Medical University and has been in practice 9 years. She is experienced in neuroblastoma, oncolytic virotherapy, and translational research.
Education & Training
Nationwide Children's Hospital/Ohio State UniversityFellowship, Pediatric Hematology/Oncology, 2011 - 2014- Nationwide Children's Hospital/Ohio State UniversityResidency, Pediatrics, 2008 - 2011
Northeast Ohio Medical UniversityClass of 2008
Certifications & Licensure
OH State Medical License 2008 - 2026- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- Early Career Award American Society of Pediatric Hematology/Oncology, 2015
- House staff officer of the year Nationwide Children's Hospital, 2011
- House staff of the year Nationwide Children's Hospital, 2010
Clinical Trials
- Combination Therapy of Antibody Hu3F8 With Granulocyte- Macrophage Colony Stimulating Factor (GM-CSF) in Patients With Relapsed/Refractory High-Risk Neuroblastoma Start of enrollment: 2012 Dec 01
- Immunotherapy of Relapsed Refractory Neuroblastoma With Expanded NK Cells Start of enrollment: 2019 Jan 14
- Neuroblastoma Maintenance Therapy Trial Start of enrollment: 2016 Feb 01
- Join now to see all
Publications & Presentations
PubMed
- Incidence of Adrenal Insufficiency in Patients with High-Risk Neuroblastoma: A Single-Institution Analysis.Shachi Srivatsa, Greg Metzger, Kyle Horvath, Kelli Patterson, Megan Scruggs
Pediatric Blood & Cancer. 2025-01-21 - A Single-Institution Analysis of Surveillance Practice for Low-Risk Neuroblastic Tumors.Shachi Srivatsa, Dana Schwartz, Sara A Mansfield, Josh Bricker, Grace Mallampalli
The Journal of Surgical Research. 2025-01-13 - 2 citationsImpact of diagnostic and end-of-induction Curie scores with tandem high-dose chemotherapy and autologous transplants for metastatic high-risk neuroblastoma: A report f...Keri A Streby, Marguerite T Parisi, Barry L Shulkin, Brian LaBarre, Rochelle Bagatell
Pediatric Blood & Cancer. 2023-08-01
Professional Memberships
- Advances in Neuroblastoma Research AssociationMember
- Childrens Oncology GroupMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
